<DOC>
	<DOCNO>NCT00139074</DOCNO>
	<brief_summary>The primary purpose investigate whether addition sodium valproate superior treatment quetiapine ( Seroquel ) give monotherapy additional 14 day non-responding patient 14 day initial treatment period quetiapine . PLEASE NOTE : Seroquel SR Seroquel XR refer formulation . The SR designation change XR consultation FDA .</brief_summary>
	<brief_title>Seroquel Acute Mania : Study Investigate Valproate Add-On Therapy Superior Quetiapine Monotherapy Acutely Manic Patients</brief_title>
	<detailed_description />
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<mesh_term>Valproic Acid</mesh_term>
	<criteria>Patients suffer manic mixed episode . Patients provide personal informed consent , Known intolerance , hypersensitivity lack antimanic response sodium valproate quetiapine fumarate , Involuntary admittance/detainment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Bipolar I Disorder ( DSM-IV 296.01 , DSM-IV 296.4 , DSM-IV 296.61 )</keyword>
</DOC>